INS and type 1 diabetes mellitus: However, to avoid ketoacidosis and other adverse events, risk mitigation strategies, such as continuation of insulin and discontinuation of SGLT inhibitors on sick days, should be strictly implemented when these drugs are introduced for patients with T1D (66).